GENERAL CATALOGUE
Indoramin EP Impurity A
MM0802.02 ·
LGC Standards · Cat: MM0802.02
₹600 – ₹900 approx.This price excludes freight and taxes. Please RFQ to get the final price.
Reach 3+ verified distributors
Manufacturer product page
lgcstandards.com/US/en/Indoramin-EP-Impurity-A/p/MM0802.02
Sponsored
Catalog No: MM0802.02
CAS No: 3389-21-7
Category: Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
Brand: LGC Standards
Description
Indoramin Hydrochloride Impurity A
More from LGC Standards
Isopropyl 4-(2-Hydroxy-3-isopropylpropoxy)benzoate Hydrochloride
MM0460.29-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid
MM0947.01-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
1-(3,4-Dimethoxyphenyl)-2-methylpropan-1-one
MM0022.13
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
![4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (N2-Tritylolmesartan)](https://assets.lgcstandards.com/sys-master%2Fimages%2Fhba%2Fhec%2F10587418591262%2F58597.png)
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (N2-Tritylolmesartan)
MM1317.31-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
![4′-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl][1,1′-biphenyl]-2-carboxamide (Telmisartan Amide)](https://assets.lgcstandards.com/sys-master%2Fimages%2Fha4%2Fha2%2F10868011991070%2F5028.png)
4′-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl][1,1′-biphenyl]-2-carboxamide (Telmisartan Amide)
MM0939.06-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
![Ethyl (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate](https://assets.lgcstandards.com/sys-master%2Fimages%2Fh39%2Fhef%2F10596300652574%2FS485035.png)
Ethyl (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
MM0158.21-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
(S)-(+)-4-Phenyloxazolidin-2-one
MM0935.08-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol
Quinapril Benzyl Ester Maleate
MM0628.07-0025
Impurity Reference Materials ,Cardiac drugs and beta blockers,Mikromol, Impurity Reference Materials ,, Cardiac drugs and beta blockers,, Mikromol